Skip to main content

Imbalances in funding for clinical and public health research in the UK: can NICE research recommendations make a difference?

Buy Article:

$36.95 plus tax (Refund Policy)

Abstract:

National Institute for Health and Clinical Excellence (NICE) recommendations for further research often focus on access, prevention and health promotion, and include population groups traditionally excluded from clinical trials, such as children and minority ethnic groups. NICE and its advisory bodies are starting to work with the National Institute for Health Research to promote research into the clinical and cost-effectiveness of public health interventions. More streamlined interaction between public funders and policy makers could help drive public R&D (Research & Development) investment towards under-researched areas such as prevention, equity and access, and strengthen the evidence base that underpins NICE guidance and broader clinical and public health practice in the UK.

Keywords: NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE; NICE; PUBLIC HEALTH; RESEARCH PRIORITIES

Document Type: Regular Paper

DOI: https://doi.org/10.1332/174426408X366667

Publication date: 2008-11-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
UA-1313315-21
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more